Athena Athena

X

Find the latest Drugs in Development and Pipeline Prospector News of Aragen Life Sciences.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Aragen Life Sciences
india-flag Flag
Country
Country
India
Address
Address
28 A, IDA Nacharam Hyderabad 500 076, India
Telephone
Telephone
+91 40 6692 9999

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the collaboration, Aragen will deploy its proven experimental integrated drug discovery (IDD) platform to help FAR advance its small molecule program towards an important milestone in neurodegeneration.


Lead Product(s): Undisclosed

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: FAR Biotech

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 30, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

In accordance with the agreement, Aragen will do a process optimization and synthesis, manufacturing and supply of MEAI to Clearmind.


Lead Product(s): 5-Methoxy-2-Aminoindane

Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: Clearmind Medicine

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement October 26, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Xentuzumab* (BI 836845) is a humanized immunoglobulin G (IgG) 1 monoclonal antibody (mAb) that targets insulin-like growth factor (IGF) ligands IGF-1 and IGF-2 for treatment of breast cancer.


Lead Product(s): Xentuzumab,Everolimus,Exemestane

Therapeutic Area: Oncology Product Name: BI 836845

Highest Development Status: Phase IIProduct Type: Large molecule

Partner/Sponsor/Collaborator: Boehringer Ingelheim GmbH

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement June 29, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The aim of this partnership is to identify the uPRIT with the optimal urokinase plasminogen activator receptor binding profile, enabling selective delivery of a cytotoxic radioisotope to just those aberrantly activated immune cells that produce the cytokine storm.


Lead Product(s): MNPR-101

Therapeutic Area: Infections and Infectious Diseases Product Name: MNPR-101

Highest Development Status: PreclinicalProduct Type: Large molecule

Partner/Sponsor/Collaborator: Monopar Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership August 19, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under the terms of the collaboration, Aragen is set to provide Serum with high expressing cell lines enabling Serum to quickly move their RapTr™ platform forward into Manufacturing.


Lead Product(s): CHO-DG44

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Serum Institute of India Private Limited

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration January 08, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY